Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Mallinckrodt Plc (NYSE:MNK)

46.24
Delayed Data
As of Jun 26
 -0.08 / -0.17%
Today’s Change
38.80
Today|||52-Week Range
85.83
-7.19%
Year-to-Date

Today’s Trading

Previous close46.32
Today’s open46.49
Day’s range46.01 - 47.04
Volume2,065,166
Average volume (3 months)2,108,386
Market cap$4.6B
Dividend yield--
Data as of 06/26/2017

Growth & Valuation

Earnings growth (last year)+78.72%
Earnings growth (this year)--
Earnings growth (next 5 years)+9.00%
Revenue growth (last year)+1.01%
P/E ratio25.3
Price/Sales2.30
Price/Book0.94

Competitors

 Today’s
change
Today’s
% change
CLVSClovis Oncology Inc-0.54-0.57%
CTLTCatalent Inc-0.50-1.34%
TAROTaro Pharmaceutical ...+0.19+0.16%
AGNPRAAllergan plc+9.03+1.03%
Data as of 06/26/2017

Financials

Next reporting dateAugust 8, 2017
EPS forecast (this quarter)$1.73
Annual revenue (last year)$3.4B
Annual profit (last year)$548.0M
Net profit margin14.46%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Mark C. Trudeau
Senior Vice President-
Global Operations
Frank Scholz
Corporate headquarters
Chesterfield, Derbyshire

Forecasts